Generic Name: eflornithine topical (ee FLOOR nih theen)
Brand Names: Vaniqa
What is Vaniqa?
Vaniqa interferes with a chemical in the hair follicles of the skin. This results in slower hair growth where the cream is applied.
Vaniqa is used to reduce unwanted facial hair in women. It does not permanently remove hair or "cure" unwanted facial hair. However it will help you manage your condition and improve your appearance.
Vaniqa may also be used for purposes other than those listed in this medication guide.
Vaniqa is for external use only.
Continue to use Vaniqa even if you do not see immediate results. Reduction in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment should be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment.
Who should not use Vaniqa?
Do not use Vaniqa if you have had an allergic reaction to it in the past.
Vaniqa is in the FDA pregnancy category C. This means that it is not known whether eflornithine will harm an unborn baby. Do not use this medication without first talking to your doctor if you are pregnant. It is also not known whether eflornithine passes into breast milk. Do not use this medicine without first talking to your doctor if you are breast-feeding a baby. This medicine has not been approved for use by children younger than 12 years of age.
How should I use Vaniqa?
Apply Vaniqa exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.
Vaniqa does not permanently remove hair or "cure" unwanted facial hair. It is not a hair remover (depilatory). You will need to continue using your current hair removal techniques. Vaniqa will help you manage your condition and improve your appearance.
his medicine is for external use only.
The cream is usually applied twice daily, at least eight hours apart, or as directed by your doctor.
Wash your hands before and after each application.
Remove any facial hair that is present using your current hair removal techniques. Wait at least 5 minutes after hair removal before applying Vaniqa. Apply a thin layer of cream to the affected areas of the face and nearby affected areas under the chin and rub it in thoroughly.
Cosmetics or sunscreen may be used after applying Vaniqa, but you should wait a few minutes to allow the treatment to be absorbed before applying them.
Do not wash the treatment areas for at least 4 hours after application. Avoid getting this medication in your eyes, nose, or mouth. If this occurs, wash the area with water. If the cream gets in your eyes, rinse them thoroughly with water and contact your doctor.
Vaniqa may cause temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application of Vaniqa to once a day. If irritation continues, stop using the cream and contact your doctor.
Continue to use the cream even if you do not see immediate results. Reduction in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment should be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment.
Store this medicine at room temperature away from moisture and heat. Do not allow the medication to freeze.
What happens if I miss a dose?
If you miss a dose of Vaniqa, skip the dose you missed and apply your next regularly scheduled dose as directed. Do not apply a double dose of this medication or try to "make up" a missed dose.
What happens if I overdose?
An overdose is not likely to occur. If the cream has been ingested, or if you suspect an overdose has occurred, contact your doctor, hospital emergency room, or poison control center for advice.
What should I avoid?
Avoid getting this medication in your eyes, nose, or mouth. If this occurs, wash the area with water. If Vaniqa gets in your eyes, rinse thoroughly with water and contact your doctor.
Vaniqa side effects
Vaniqa may cause temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application to once a day. If irritation continues, stop using Vaniqa and contact your doctor.
Hair bumps (folliculitis) may also occur. If these continue, contact your doctor.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
What other drugs will affect Vaniqa?
Before using Vaniqa, talk to your doctor if you are taking any other prescription or over-the-counter medications, especially if you are using any other topical preparations. You may not be able to use this medicine, or you may require a dosage adjustment or special monitoring during treatment.
Drugs other than those listed here may also interact with Vaniqa. Talk to your doctor and pharmacist before taking or using any other prescription or over-the-counter medicines.
More about Vaniqa (eflornithine topical)
Related treatment guides
Where can I get more information?
- Your pharmacist has additional information about Vaniqa written for health professionals that you may read.
What does my medication look like?
Eflornithine topical is available with a prescription under the brand name Vaniqa. Other brand or generic formulations of this medication may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.
Vaniqa cream 13.9% -30 gram tube
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2016 Cerner Multum, Inc. Version: 1.04. Revision Date: 2009-04-12, 4:44:26 PM.